Ichor Life Sciences, a pre-clinical contract-research organization offering services in discovery through pharmacology, announces the hiring of CHRISTOPHER SCHILLO as its new vivarium director to expand the company’s ophthalmology capabilities and capacity. Schillo is responsible for overseeing all operations within the vivarium, which includes managing staff, animal husbandry, and research operations as well as acting […]
Get Instant Access to This Article
Become a Central New York Business Journal subscriber and get immediate access to all of our subscriber-only content and much more.
- Critical Central New York business news and analysis updated daily.
- Immediate access to all subscriber-only content on our website.
- Get a year's worth of the Print Edition of The Central New York Business Journal.
- Special Feature Publications such as the Book of Lists and Revitalize Greater Binghamton, Mohawk Valley, and Syracuse Magazines
Click here to purchase a paywall bypass link for this article.
Ichor Life Sciences, a pre-clinical contract-research organization offering services in discovery through pharmacology, announces the hiring of CHRISTOPHER SCHILLO as its new vivarium director to expand the company’s ophthalmology capabilities and capacity. Schillo is responsible for overseeing all operations within the vivarium, which includes managing staff, animal husbandry, and research operations as well as acting as Ichor’s Institutional Animal Care and Use Committee (IACUC) chair, a requirement for all vivariums that house USDA species. Prior to joining Ichor, Schillo served as the director of preclinical operations for Ora, Inc., a provider of eye research for pharmaceutical companies, where he oversaw pre-clinical operations and provided expertise in ocular drug development. At Ichor, Schillo will augment Ichor’s current offerings, including ophthalmology, oncology, geriatrics, and more.